India's Dhunseri Group to expand packaging films business
India-based Dhunseri Group is set to invest over Rs22bn ($254.4m) by the financial year 2028-29 to enhance its flexible packaging films business through both greenfield and brownfield projects, says Business Standard.
The investment aims to expand production capacity and cater to the growing market demand.
For the greenfield project in Kathua, Jammu and Kashmir, the group has earmarked an investment of about Rs12.4bn. Additionally, approximately Rs10bn will be allocated for the brownfield project at Panagarh in West Bengal.
These expansions are expected to be carried out by Dhunseri Poly Films (DPFPL), a wholly-owned subsidiary of Dhunseri Ventures.
Dhunseri Poly Films will expand its operations at Panagarh by installing at least two new production lines, one for biaxially oriented polyethylene terephthalate and another for biaxially oriented polypropylene (BOPP). The company already operates a unit at Panagarh.
The capital expenditure for the new lines at the Panagarh facility is expected to be financed with a debt-equity ratio of 70:30. These lines are expected to be operational by 2029.
The Panagarh plant, which commenced commercial production in December 2023, is now poised for further growth.
The company will add two BOPP plants at Kathua. The commercial production from the greenfield plant at Kathua is expected to commence in 2027.
Dhunseri Poly Films serves the domestic market while also exporting to Europe, Bangladesh, and Nepal, with these regions being the major overseas markets.
For the financial year 2025, Dhunseri Ventures reported a net profit of Rs142.9bn and a revenue of Rs480.4bn, indicating a strong financial position to support the planned investments.
"India's Dhunseri Group to expand packaging films business" was originally created and published by Packaging Gateway, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Warren Buffett's Top Recommendation for Investors Could Turn $500 Per Month Into $100,000 in 10 Years.
Buffett shares a lot of investment advice in his shareholder letters and annual meetings. He recommends one investment for most people, including the executor of his estate. If you consistently add to your portfolio, you could have six figures within a decade of starting. 10 stocks we like better than Vanguard S&P 500 ETF › Warren Buffett is happy to share investment advice with anyone who's interested. His annual letters to shareholders and extended question-and-answer sessions at Berkshire Hathaway's annual meetings are incomparable sources of wisdom. Buffett has been a great guide for countless successful investors who like to pick great companies, not just great stocks. But the Oracle of Omaha's top recommendation for most investors is to ignore a lot of that and keep things as simple as possible. That's because it's often the behavioral challenges of investing in individual companies that trip up those who would otherwise be successful. Buying or selling a great company at the wrong price at the wrong time is a path to underperformance. Here's what Buffett recommends instead. One of the easiest ways for investors to avoid the behavioral tripwires that can lead to lagging the stock market is to stop trying to outperform the market average in the first place. That's why Buffett's top recommendation for average investors is to put money in an index fund. He prefers the Vanguard S&P 500 ETF (NYSEMKT: VOO). Buffett plans to take his own advice, too. He instructed the executor of his estate to put 90% of his wealth in the index fund after his passing. If you consistently put aside $500 of your paycheck every month, you could be sitting on a six-figure portfolio 10 years from now, even if you're starting from nothing. Buffett doesn't think dollar-cost averaging is for active stock pickers. While he doesn't try to time the market, he does try to value companies. Buying a company's stock without regard for its value (as dictated by a dollar-cost averaging strategy) won't lead to the outperformance stock pickers seek. But when it comes to passive investing, the best way to get the most out of your money is to put all your money into the fund and consistently add to it over time with money from your earnings. Earning average returns for a long time can produce above-average wealth. The S&P 500 expanded to a 500-constituent format in March of 1957. Since then, the broad-based index has gone on to produce a compound average annual total return of 10.5%. That return is achieved by reinvesting dividends, which most brokerages allow you to do automatically. If you set up a brokerage account and automatically purchase $500 of the Vanguard S&P 500 ETF every month while reinvesting dividends, here's what you can expect if you earn average returns from the last 70 years. Years Investing Expected Value of Portfolio 1 $6,335 2 $13,335 3 $21,068 4 $29,611 5 $39,050 6 $49,477 7 $60,998 8 $73,726 9 $87,788 10 $103,324 Calculations by author. It's worth pointing out that $500 per month, or $6,000 per year, is less than the annual contribution limit for an IRA. That will ensure you keep your investments tax-deferred or even tax-free. While the Vanguard S&P 500 ETF doesn't have a history of capital gains distributions, investors still have to pay taxes on its income distributions from dividends. Those usually incur a 15% qualified dividend tax, so there's a slight tax drag. But even if you set aside 15% of each dividend distribution, you could end up with a portfolio value north of $100,000 based on average returns. If you contribute the $500 per month to an employer-sponsored retirement plan, you could end up with well over $100,000. That's because most plans include a matching contribution. While you might not have the Vanguard fund available in your plan, most include some low-cost index funds. Even with relatively high fees, that can be the easiest way to build a sizable portfolio for retirement. Charlie Munger, Warren Buffett's Vice Chairman and longtime friend, once told a young investor that the first $100,000 is the hardest. (He used more colorful language.) Once you have $100,000, you can let off the gas a bit because the returns from the portfolio will start to do some of the work for you. Indeed, if all you did was invest $500 per month for 10 years like above and let it sit for another 10 years, you'd have close to $280,000 without adding another penny. Wait 15 more years, and you'll have around $1.25 million. That's the true power of compounding, and it doesn't take any special skills or market timing knowledge to get there. Before you buy stock in Vanguard S&P 500 ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Vanguard S&P 500 ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Adam Levy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway and Vanguard S&P 500 ETF. The Motley Fool has a disclosure policy. Warren Buffett's Top Recommendation for Investors Could Turn $500 Per Month Into $100,000 in 10 Years. was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Warren Buffett's Top 7 Money Mistakes (And What He Learned From Them)
Warren Buffett didn't build his more than $100 billion fortune by being perfect. In fact, the Oracle of Omaha has been surprisingly candid about his biggest financial flubs over the decades. The good news is his mistakes offer valuable lessons for anyone trying to build real, sustainable wealth. Plus, they prove that even legendary investors are just humans who get it wrong sometimes. Welcome to the club! Find Out: Read Next: Here are Buffett's top money mistakes and, more importantly, what he learned from them. Buffett's investment in U.K. grocer Tesco shows how hesitation can turn small problems into major losses. Berkshire owned 415 million shares by 2012, but when concerns about management surfaced, Buffett sold only part of his position for a $43 million profit. When Tesco later overstated profits and shares collapsed, his delayed action cost Berkshire $444 million in after-tax losses. 'An attentive investor, I'm embarrassed to report, would have sold Tesco shares earlier. I made a big mistake with this investment by dawdling,' Buffett said. Speed matters in damage control. When red flags are abundant, sometimes quick decisive action means you avert a financial disaster. Learn More: Believe it or not, Buffett has called Berkshire Hathaway 'the dumbest stock I ever bought.' He purchased what was, at the time, a failing textile company because he felt insulted during a sale negotiation. Instead of walking away from Berkshire Hathaway as planned, his wounded pride led him to buy the entire business and fire the previous owner. The financial cost was enormous. Buffett said his holding company would be 'worth twice as much as it is now' if he'd stuck to his original plan of investing in insurance companies instead. This single emotional reaction cost him decades of better returns. The takeaway is clear: Never let personal feelings influence money decisions. When you feel personally slighted in a financial deal, that's exactly when you need to step back, take a breath and think logically. In 1993, Buffett thought Dexter Shoes had lasting competitive advantages that would protect its profits. Within a few years, those advantages evaporated and the company became worthless. Buffett explained: 'What I had assessed as a durable competitive advantage vanished within a few years.' This loss taught him that 'a truly great business must have an enduring 'moat' that protects excellent returns on invested capital.' Companies need permanent moats — like unbeatable brands, exclusive technology or cost advantages — that competitors can't easily copy. Without sustainable protection, any successful business will eventually attract competitors who'll drive profits to zero. The key is finding businesses whose advantages will last decades, not just a few good years. This mistake still haunts Buffett. Despite owning Geico insurance, which spent millions on Google advertising, he completely missed the search giant's investment potential. He had firsthand evidence of Google's business model working but failed to connect the dots. 'I made the mistake in not being able to come to a conclusion where I really felt that at the present prices, the prospects were far better than the prices indicated,' Buffett admitted. His reluctance to venture beyond familiar territory cost him one of the greatest investment opportunities in history. The lesson here is about missed opportunities. Sometimes the best investments are hiding in plain sight, but we ignore them because they seem too complicated or unfamiliar. Buffett's $9 billion acquisition of Lubrizol Corporation became an issue when it emerged that David Sokol, a Berkshire executive who recommended the deal, secretly owned stock in the company. Sokol made $3 million from the transaction without disclosing his conflict of interest. The oversight violated insider-trading rules and hurt Berkshire's reputation. At the 2011 annual meeting, Buffett said he should have asked better, more direct questions about Sokol's involvement. The lesson? Trust but verify, especially when large sums are involved. Even with people you've worked with (or simply known) for years, asking uncomfortable questions can prevent you from making mistakes. When crude oil hit $100+ per barrel in 2008, Buffett jumped into ConocoPhillips stock expecting energy prices to keep climbing. Instead, he bought at the peak and watched the investment lose billions as oil crashed. This demonstrates how even smart investors can get caught up in market excitement. 'When investing, pessimism is your friend, euphoria the enemy,' Buffett has said. When everyone is optimistic about a sector, prices often reflect that optimism, leaving little room for profit. Buffett learned that great companies can still be terrible investments if you pay the wrong price. Market euphoria creates expensive stocks, while pessimism creates bargains. The best time to buy is when others are selling, not when everyone else is buying too. U.S. Air's impressive revenue numbers looked very attractive in 1989, so Buffett bought preferred shares. Bad news for Buffett, those revenues came with a hidden cost. Airlines need constant capital to grow, buying new planes and expanding routes, leaving little for shareholders. By the time the airline achieved meaningful profits, debt payments ate up most of the returns. The company couldn't even pay dividends on Buffett's preferred stock. He got lucky selling at a profit later, but knew it was pure chance. This taught him to distinguish between real growth and expensive growth. As Buffett said, 'Investors have poured money into a bottomless pit, attracted by growth when they should have been repelled by it.' Some businesses need to spend huge amounts just to increase sales, leaving shareholders with nothing. The lesson is: If it looks too good to be true, it just might be. What makes Buffett extraordinary isn't his perfect track record, it's his willingness to admit errors publicly and extract valuable lessons from them. Each mistake became a teaching moment that improved his future decisions. His Google miss made him more open to technology investments, eventually leading to major positions in Apple. His ConocoPhillips overpayment reinforced his discipline about buying only at attractive prices. His Dexter Shoes loss sharpened his focus on truly durable competitive advantages. The real wisdom isn't avoiding all mistakes. Unfortunately, that's impossible. It's learning from failures quickly and adjusting your approach. Buffett's biggest errors became steppingstones to better investing, not permanent setbacks. For the rest of us, it's a lesson in endurance. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 10 Used Cars That Will Last Longer Than an Average New Vehicle 8 Common Mistakes Retirees Make With Their Social Security Checks This article originally appeared on Warren Buffett's Top 7 Money Mistakes (And What He Learned From Them) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
We're Not Very Worried About Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. Given this risk, we thought we'd take a look at whether Cartesian Therapeutics (NASDAQ:RNAC) shareholders should be worried about its cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. First, we'll determine its cash runway by comparing its cash burn with its cash reserves. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In March 2025, Cartesian Therapeutics had US$180m in cash, and was debt-free. Importantly, its cash burn was US$40m over the trailing twelve months. Therefore, from March 2025 it had 4.5 years of cash runway. There's no doubt that this is a reassuringly long runway. Depicted below, you can see how its cash holdings have changed over time. Check out our latest analysis for Cartesian Therapeutics We reckon the fact that Cartesian Therapeutics managed to shrink its cash burn by 31% over the last year is rather encouraging. On top of that, operating revenue was up 32%, making for a heartening combination It seems to be growing nicely. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company. There's no doubt Cartesian Therapeutics seems to be in a fairly good position, when it comes to managing its cash burn, but even if it's only hypothetical, it's always worth asking how easily it could raise more money to fund growth. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year (at the same burn rate). Cartesian Therapeutics has a market capitalisation of US$260m and burnt through US$40m last year, which is 16% of the company's market value. Given that situation, it's fair to say the company wouldn't have much trouble raising more cash for growth, but shareholders would be somewhat diluted. It may already be apparent to you that we're relatively comfortable with the way Cartesian Therapeutics is burning through its cash. For example, we think its cash runway suggests that the company is on a good path. Its weak point is its cash burn relative to its market cap, but even that wasn't too bad! Considering all the factors discussed in this article, we're not overly concerned about the company's cash burn, although we do think shareholders should keep an eye on how it develops. Separately, we looked at different risks affecting the company and spotted 5 warning signs for Cartesian Therapeutics (of which 3 don't sit too well with us!) you should know about. If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
